...Phase I Preventative Vaccine Trial in the U.S. and Africa
Epimmune's HIV Vaccine Candidate Taken by the National Institutes of Health and HIV Vaccine Trials Network Into Phase I Preventative Vaccine Trial in the U.S. and Africa SAN DIEGO, April 7 /PRNewswire-FirstCall/ -- Epimmune Inc., today announced that the National Institute of Allergy and Infectious... Sign in to see full entry.